Trial: 202010122

A Phase 2 Study of Anti-PD-L1 Antibody (Atezolizumab) in Chondrosarcoma and Clear Cell Sarcoma

Phase

II

Principal Investigator

Van Tine, Brian

Disease Site

Bones and Joints; Soft Tissue

Learn more about this study at: clinicaltrials.gov